WS #16605
As risk appetite evaporates, capital is rotating into defensive sectors. Eli Lilly and AbbVie are posting strong gains driven by earnings beats and robust demand for diabetes and weight-loss drugs. Investors are pivoting to low-volatility stocks and payment giants, which are leading the week's EPS beats. This rotation highlights a clear divergence: while high-multiple tech and hardware face existential or cyclical headwinds, healthcare and financials are providing a safe harbor.
Defensive Rotation and Healthcare Strength
As risk appetite evaporates, capital is rotating into defensive sectors. Eli Lilly and AbbVie are posting strong gains driven by earnings beats and robust demand for diabetes and weight-loss drugs. Investors are pivoting to low-volatility stocks and payment giants, which are leading the week's EPS beats. This rotation highlights a clear divergence: while high-multiple tech and hardware face existential or cyclical headwinds, healthcare and financials are providing a safe harbor.